560 related articles for article (PubMed ID: 25804672)
21. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
Jiang B; Li T; Guo L; Shen H; Ye S; Chen S
J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
[TBL] [Abstract][Full Text] [Related]
22. Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE.
Esteves GCX; Gormezano NWS; Pereira OL; Kern D; Silva CA; Pereira RMR; Kozu KT; Bonfá E; Aikawa NE
Mod Rheumatol; 2018 Jul; 28(4):649-653. PubMed ID: 29067848
[TBL] [Abstract][Full Text] [Related]
23. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups.
Lopes SRM; Gormezano NWS; Gomes RC; Aikawa NE; Pereira RMR; Terreri MT; Magalhães CS; Ferreira JC; Okuda EM; Sakamoto AP; Sallum AME; Appenzeller S; Ferriani VPL; Barbosa CM; Lotufo S; Jesus AA; Andrade LEC; Campos LMA; Bonfá E; Silva CA;
Lupus; 2017 Aug; 26(9):996-1001. PubMed ID: 28134038
[TBL] [Abstract][Full Text] [Related]
25. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
[TBL] [Abstract][Full Text] [Related]
26. Successful Treatment with Rituximab in a Patient with Castleman's Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia.
Zhang L; Jiao L; Wang SJ
Chin Med J (Engl); 2015 Sep; 128(18):2551-2. PubMed ID: 26365980
[No Abstract] [Full Text] [Related]
27. Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases.
Reis J; Aguiar F; Brito I
Acta Reumatol Port; 2016; 41(1):45-55. PubMed ID: 27115107
[TBL] [Abstract][Full Text] [Related]
28. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
29. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.
Li H; Ji J; Du Y; Huang Y; Gu H; Chen M; Wu R; Han B
Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553
[TBL] [Abstract][Full Text] [Related]
30. Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune Cytopenia.
Ottaviano G; Marinoni M; Graziani S; Sibson K; Barzaghi F; Bertolini P; Chini L; Corti P; Cancrini C; D'Alba I; Gabelli M; Gallo V; Giancotta C; Giordano P; Lassandro G; Martire B; Angarano R; Mastrodicasa E; Bava C; Miano M; Naviglio S; Verzegnassi F; Saracco P; Trizzino A; Biondi A; Pignata C; Moschese V
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):273-282. PubMed ID: 31377437
[TBL] [Abstract][Full Text] [Related]
31. Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.
Khojah AM; Miller ML; Klein-Gitelman MS; Curran ML; Hans V; Pachman LM; Fuleihan RL
Pediatr Rheumatol Online J; 2019 Aug; 17(1):61. PubMed ID: 31462263
[TBL] [Abstract][Full Text] [Related]
32. Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHA.
Laribi K; Bolle D; Ghnaya H; Sandu A; Besançon A; Denizon N; Truong C; Pineau-Vincent F; de Materre AB
Ann Hematol; 2016 Apr; 95(5):765-9. PubMed ID: 26858026
[TBL] [Abstract][Full Text] [Related]
33. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).
Scheinberg M; Hamerschlak N; Kutner JM; Ribeiro AA; Ferreira E; Goldenberg J; Kiss MH; Chahade WH
Clin Exp Rheumatol; 2006; 24(1):65-9. PubMed ID: 16539821
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment.
Neely J; von Scheven E
Curr Opin Rheumatol; 2018 Sep; 30(5):498-505. PubMed ID: 29979258
[TBL] [Abstract][Full Text] [Related]
35. Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.
Hundae A; Peskoe S; Grimsley E; Patel S
South Med J; 2008 Sep; 101(9):943-4. PubMed ID: 18708978
[TBL] [Abstract][Full Text] [Related]
36. Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus - Single Center Experience in Croatia.
Sršen S; Frković M; Malčić I; Jelušić M
Acta Dermatovenerol Croat; 2020 Aug; 28(2):63-69. PubMed ID: 32876030
[TBL] [Abstract][Full Text] [Related]
37. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
Peñalver FJ; Alvarez-Larrán A; Díez-Martin JL; Gallur L; Jarque I; Caballero D; Díaz-Mediavilla J; Bustelos R; Fernández-Aceñero MJ; Cabrera JR;
Ann Hematol; 2010 Nov; 89(11):1073-80. PubMed ID: 20526716
[TBL] [Abstract][Full Text] [Related]
38. A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.
Tanaka Y; Yamamoto K; Takeuchi T; Nishimoto N; Miyasaka N; Sumida T; Shima Y; Takada K; Matsumoto I; Saito K; Koike T
Mod Rheumatol; 2007; 17(3):191-7. PubMed ID: 17564773
[TBL] [Abstract][Full Text] [Related]
39. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
40. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]